133 related articles for article (PubMed ID: 2576202)
1. Evaluation of the therapeutic effect of transdermal beta-blocker therapy in patients with essential hypertension.
Spieker C; Vetter W; Zidek W; Vetter H
Arzneimittelforschung; 1989 Nov; 39(11A):1512-4. PubMed ID: 2576202
[TBL] [Abstract][Full Text] [Related]
2. Transdermal beta-blocker therapy in essential hypertension.
Spieker C; Vetter H; Liedtke R; Zidek W; Vetter W
Am J Hypertens; 1988 Jul; 1(3 Pt 3):199S-200S. PubMed ID: 2901265
[TBL] [Abstract][Full Text] [Related]
3. [Anti-ischemic action of the transdermally-applied beta-receptor blocker, mepindolol, in patients with stable angina pectoris. Comparison with transdermal nitrate].
Bonelli J; Gazo F; Falkner C; Liedtke RK
Arzneimittelforschung; 1990 Aug; 40(8):876-9. PubMed ID: 1978680
[TBL] [Abstract][Full Text] [Related]
4. [Anti-ischemic action of the transdermally applied beta-receptor blocker, mepindolol in patients with stable angina pectoris].
Bonelli J; Gazo F; Liedtke RK
Arzneimittelforschung; 1989 Nov; 39(11A):1515-7. PubMed ID: 2576203
[TBL] [Abstract][Full Text] [Related]
5. [Human pharmacologic studies on transdermal administration of mepindolol. Pharmacodynamic and orienting pharmacokinetics].
Liedtke RK; Chen LS; Mangold B; Haase W
Arzneimittelforschung; 1989 Nov; 39(11A):1501-4. PubMed ID: 2576199
[TBL] [Abstract][Full Text] [Related]
6. Multicenter evaluation of mepindolol and of mepindolol plus hydrochlorothiazide in essential hypertension.
Masoni A; Galassi A; Ginevrino P; Libretti A; Morgagni W; Rappelli A; Tomasi AM
Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):546-50. PubMed ID: 6757152
[TBL] [Abstract][Full Text] [Related]
7. Isradipine in monotherapy and in combination with bopindolol: results of a 3-month multicentre study in hypertensives.
Dzúrik R; Fetkovská N; Dvorák I; Jonás P; Markuljak I; Petr P; Kotlík I; Widimský J
Cor Vasa; 1990; 32(2 Suppl 1):42-53. PubMed ID: 1974488
[TBL] [Abstract][Full Text] [Related]
8. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of hypertension with a fixed combination of bopindolol and chlorthalidone (Sandoretic)].
Widimský J; Lánská V; Hulínský V; Balazovjech I; Havlík V; Havránek P; Kroupa E; Nikodýmová L; Pátek F; Svítil F; Svihovcová P
Vnitr Lek; 1996 Apr; 42(4):223-8. PubMed ID: 8693706
[TBL] [Abstract][Full Text] [Related]
10. Transdermal monotherapy with mepindolol BIO TSD in patients with stable angina pectoris. Placebo-controlled, crossover investigation of a new therapeutic concept with 12-hours overnight application.
Bonelli J; Gazo F; Kirsch P; Liedtke RK
Int J Clin Pharmacol Ther Toxicol; 1991 Nov; 29(11):425-30. PubMed ID: 1800388
[TBL] [Abstract][Full Text] [Related]
11. Bopindolol in the treatment of hypertension: a double blind study comparing bopindolol and metoprolol.
Lefflerová K; Lupínek Z; Widimský J; Lupínková Z; Uhlír O; Miklis P; Zeman K; Zicha J
Cor Vasa; 1989; 31(5):387-93. PubMed ID: 2575480
[TBL] [Abstract][Full Text] [Related]
12. [The blood pressure profile, or how to establish the minimal effective dose of an antihypertensive agent].
Abetel G
Rev Med Suisse Romande; 1988 Jun; 108(6):529-33. PubMed ID: 2901140
[No Abstract] [Full Text] [Related]
13. [The antihypertensive efficacy and tolerance of bopindolol (LT 31-200) in hypertensive patients].
Honorato J; Galende I; Catalán M; Azanza JR
Rev Med Univ Navarra; 1990; 34(2):90-4. PubMed ID: 1983366
[TBL] [Abstract][Full Text] [Related]
14. [Transdermal beta blockers: effect on 24-hour blood pressure profile in hypertensive patients].
Spieker C; Vetter W; Hany S; Liedke R; Vetter H
Schweiz Rundsch Med Prax; 1987 Apr; 76(17):467-8. PubMed ID: 3602765
[No Abstract] [Full Text] [Related]
15. One year efficacy and tolerability of clonidine administered by the transdermal route in patients with mild to moderate essential hypertension--a multicentre open label study. The Antihypertensive Patch Italian Study (APIS) Investigators.
Clin Auton Res; 1993 Dec; 3(6):379-83. PubMed ID: 8193525
[TBL] [Abstract][Full Text] [Related]
16. Bopindolol, a new long-acting beta-adrenoceptor antagonist--a randomized comparison against propranolol in hypertensive patients.
Kirch W; Axthelm T
Int J Clin Pharmacol Res; 1983; 3(2):89-93. PubMed ID: 6148312
[TBL] [Abstract][Full Text] [Related]
17. Chronobiological approach to the treatment of essential hypertension: preliminary data.
Lauro R; Reda G; del Mastro S; Ottolenghi L; Sesti G
Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):630-6. PubMed ID: 6500760
[TBL] [Abstract][Full Text] [Related]
18. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
von Fallois J; Faülhaber HD
Fortschr Med Orig; 2000 Jul; 118 Suppl 2():77-82. PubMed ID: 15700490
[TBL] [Abstract][Full Text] [Related]
19. Transdermal delivery of mepindolol and propranolol in normal man. 1st communication: study design, clinical and pharmacodynamic aspects.
de Mey C; Enterling D; Ederhof M; Wesche H; Osterwald H
Arzneimittelforschung; 1989 Nov; 39(11A):1505-8. PubMed ID: 2576200
[TBL] [Abstract][Full Text] [Related]
20. Beta-adrenergic blocking agents in the treatment of pregnancy-induced hypertension.
Paran E; Holzberg G; Mazor M; Zmora E; Insler V
Int J Clin Pharmacol Ther; 1995 Feb; 33(2):119-23. PubMed ID: 7757311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
